These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Performance evaluation program for Mycobacterium tuberculosis drug-susceptibility testing process. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 1994 Jan; 43(1):17-8. PubMed ID: 8272047 [No Abstract] [Full Text] [Related]
48. High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China. Chen L; Li N; Liu M; Zhang J; Zhang H J Antimicrob Chemother; 2011 Oct; 66(10):2435-7. PubMed ID: 21795258 [No Abstract] [Full Text] [Related]
49. Multidrug-resistant tuberculosis of the spine--is it the beginning of the end? A study of twenty-five culture proven multidrug-resistant tuberculosis spine patients. Pawar UM; Kundnani V; Agashe V; Nene A; Nene A Spine (Phila Pa 1976); 2009 Oct; 34(22):E806-10. PubMed ID: 19829244 [TBL] [Abstract][Full Text] [Related]
50. [Reasons for drug-resistant tuberculosis emergence]. Tu DH Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006 [No Abstract] [Full Text] [Related]
51. [Shorter treatment of pulmonary tuberculosis is only acceptable with at least 4 drugs in the initial combination of tuberculostatic agents]. Veen J Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2164-7. PubMed ID: 8984351 [No Abstract] [Full Text] [Related]
53. [The problems in the chemotherapy of tuberculosis taking into account new data on its causative organism]. Egorov AM; Sazykin IuO Antibiot Khimioter; 2000; 45(5):3-5. PubMed ID: 10862346 [No Abstract] [Full Text] [Related]
54. Linked pyridinyl-thiadiazoles: Design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis. Mahajan NS; Dhawale SC Eur J Med Chem; 2015 Sep; 102():243-8. PubMed ID: 26280920 [TBL] [Abstract][Full Text] [Related]